EcoHIV/NDK-NanoLuc, A Fluorescein-Labeled Virus Permits to Investigate HIV-1 Infection in Mice
Authors: 
Yan Ma, Qiying Yu, Xiaohong He, Zhihong Song, Silang Yang, Yu Sun, Qihang Lv, Tingyu Xie, Hao Tian, Chaojiang GuAuthors Info & Claims
Pages 127 - 132
Abstract
EcoHIV/NDK is a recombinant virus modified from HIV-1 that uses mice as a host. NanoLuc (Nluc) luciferase is a genetically engineered small molecule enzyme (19.1kDa). It is currently the best bioluminescence reporter gene which uses furimazine as a luminescent substrate to produce detectable fluorescence. In order to quantify and locate the levels of EcoHIV/NDK infection and expression, the EcoHIV/NDK plasmid and the Nluc luciferase gene were integrated together to construct EcoHIV/NDK-NanoLuc virus. To verify whether EcoHIV/NDK-NanoLuc is effective in in vivo and in vitro, we conducted the following experiments. First, the existence of the nanoluc fragment in the recombinant plasmid was verified by PCR amplification, and then the correctness of the plasmid construction was verified by restriction enzyme digestion. As a result, the correct recombinant and plasmid were constructed. The Nluc luciferase reporter gene was used to indicate the infection of the successfully packaged virus on Hela-mCAT cells and the three strains of Kunming mice, BALB/c nude mice, and 129S2/SvPasCrl mice, respectively. Our results show that EcoHIV/NDK-NanoLuc can effectively infect Hela-mCAT cells and three strains of mice, in which viral replication site and distribution was detected through the luciferase reporter gene.
References
[1]
Gao, F., Bailes, E., Robertson, D. L., Chen, Y., Rodenburg, C. M., Michael, S. F., Cummins, L. B., Arthur, L. O., Peeters, M., Shaw, G. M., Sharp, P. M., & Hahn, B. H. (1999). Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature, 397(6718), 436–441. https://doi.org/10.1038/17130
[2]
Da L T, Lin M . Opening dynamics of HIV-1 gp120 upon receptor binding is dictated by a key hydrophobic core[J]. Physical Chemistry Chemical Physics, 2019, 21(47).
[3]
Potash, M. J., Chao, W., Bentsman, G., Paris, N., Saini, M., Nitkiewicz, J., Belem, P., Sharer, L., Brooks, A. I., & Volsky, D. J. (2005). A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proceedings of the National Academy of Sciences of the United States of America, 102(10), 3760–3765. https://doi.org/10.1073/pnas.0500649102
[4]
Davey, R. A., Hamson, C. A., Healey, J. J., & Cunningham, J. M. (1997). In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. Journal of virology, 71(11), 8096–8102. https://doi.org/10.1128/JVI.71.11.8096-8102.1997
[5]
Devés, R., & Boyd, C. A. (1998). Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiological reviews, 78(2), 487–545. https://doi.org/10.1152/physrev.1998.78.2.487
[6]
Saylor, D., Dickens, A. M., Sacktor, N., Haughey, N., Slusher, B., Pletnikov, M., Mankowski, J. L., Brown, A., Volsky, D. J., & McArthur, J. C. (2016). HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. Nature reviews. Neurology, 12(5), 309. https://doi.org/10.1038/nrneurol.2016.53
[7]
Hadas, E., Chao, W., He, H., Saini, M., Daley, E., Saifuddin, M., Bentsman, G., Ganz, E., Volsky, D. J., & Potash, M. J. (2013). Transmission of chimeric HIV by mating in conventional mice: prevention by pre-exposure antiretroviral therapy and reduced susceptibility during estrus. Disease models & mechanisms, 6(5), 1292–1298. https://doi.org/10.1242/dmm.012617
[8]
Gorantla, S., Poluektova, L., & Gendelman, H. E. (2012). Rodent models for HIV-associated neurocognitive disorders. Trends in neurosciences, 35(3), 197–208. https://doi.org/10.1016/j.tins.2011.12.006
[9]
Goffinet, C., Homann, S., Ambiel, I., Tibroni, N., Rupp, D., Keppler, O. T., & Fackler, O. T. (2010). Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu. Journal of virology, 84(8), 4089–4094. https://doi.org/10.1128/JVI.01549-09
[10]
Jin, S., Tian, S., Luo, M., Xie, W., Liu, T., Duan, T., Wu, Y., & Cui, J. (2017). Tetherin Suppresses Type I Interferon Signaling by Targeting MAVS for NDP52-Mediated Selective Autophagic Degradation in Human Cells. Molecular cell, 68(2), 308–322.e4. https://doi.org/10.1016/j.molcel.2017.09.005
[11]
Gorantla, S., Makarov, E., Finke-Dwyer, J., Castanedo, A., Holguin, A., Gebhart, C. L., Gendelman, H. E., & Poluektova, L. (2010). Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. The American journal of pathology, 177(6), 2938–2949. https://doi.org/10.2353/ajpath.2010.100536
[12]
Rongvaux, A., Takizawa, H., Strowig, T., Willinger, T., Eynon, E. E., Flavell, R. A., & Manz, M. G. (2013). Human hemato-lymphoid system mice: current use and future potential for medicine. Annual review of immunology, 31, 635–674. https://doi.org/10.1146/annurev-immunol-032712-095921
[13]
Shipunova V O, Shilova O N, Shramova E I, A Highly Specific Substrate for NanoLUC Luciferase Furimazine Is Toxic in vitro and in vivo[J]. Russian Journal of Bioorganic Chemistry, 2018, 44(2):225-228.
[14]
Boute, N., Lowe, P., Berger, S., Malissard, M., Robert, A., & Tesar, M. (2016). NanoLuc Luciferase - A Multifunctional Tool for High Throughput Antibody Screening. Frontiers in pharmacology, 7, 27. https://doi.org/10.3389/fphar.2016.00027
[15]
England, C. G., Ehlerding, E. B., & Cai, W. (2016). NanoLuc: A Small Luciferase Is Brightening Up the Field of Bioluminescence. Bioconjugate chemistry, 27(5), 1175–1187. https://doi.org/10.1021/acs.bioconjchem.6b00112
[16]
Hadas, E., Borjabad, A., Chao, W., Saini, M., Ichiyama, K., Potash, M. J., & Volsky, D. J. (2007). Testing antiretroviral drug efficacy in conventional mice infected with chimeric HIV-1. AIDS (London, England), 21(8), 905–909. https://doi.org/10.1097/QAD.0b013e3281574549
[17]
Yoon, V., Fridkis-Hareli, M., Munisamy, S., Lee, J., Anastasiades, D., & Stevceva, L. (2010). The GP120 molecule of HIV-1 and its interaction with T cells. Current medicinal chemistry, 17(8), 741–749. https://doi.org/10.2174/092986710790514499
[18]
Browning Paul, J., Wang, E. J., Pettoello-Mantovani, M., Raker, C., Yurasov, S., Goldstein, M. M., Horner, J. W., Chan, J., & Goldstein, H. (2000). Mice transgenic for monocyte-tropic HIV type 1 produce infectious virus and display plasma viremia: a new in vivo system for studying the postintegration phase of HIV replication. AIDS research and human retroviruses, 16(5), 481–492. https://doi.org/10.1089/088922200309142
[19]
He H, Sharer LR, Chao W, Gu CJ, Borjabad A, Hadas E, Kelschenbach J, Ichiyama K, Do M, Potash MJ, Volsky DJ. Enhanced human immunodeficiency virus Type 1 expression and neuropathogenesis in knockout mice lacking Type I interferon responses. J Neuropathol Exp Neurol. 2014 Jan;73(1):59-71. 24335529; PMCID: PMC3871403.
[20]
Kelschenbach, J. L., Saini, M., Hadas, E., Gu, C. J., Chao, W., Bentsman, G., Hong, J. P., Hanke, T., Sharer, L. R., Potash, M. J., & Volsky, D. J. (2012). Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 7(2), 380–387. https://doi.org/10.1007/s11481-011-9316-1
[21]
Gu, C. J., Borjabad, A., Hadas, E., Kelschenbach, J., Kim, B. H., Chao, W., Arancio, O., Suh, J., Polsky, B., McMillan, J., Edagwa, B., Gendelman, H. E., Potash, M. J., & Volsky, D. J. (2018). EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment. PLoS pathogens, 14(6), e1007061. https://doi.org/10.1371/journal.ppat.1007061
[22]
Teodorof-Diedrich, C., & Spector, S. A. (2018). Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons. Journal of virology, 92(22), e00993-18. https://doi.org/10.1128/JVI.00993-18
Recommendations
Highly conserved and associated HIV-1 CTL and T-Helper epitopes in global HIV-1 population: potential candidates for multi-epitope HIV-1 vaccine
BCB '10: Proceedings of the First ACM International Conference on Bioinformatics and Computational BiologyHuman Immunodeficiency Virus (HIV-1), one of the fastest evolving organisms, is a leading cause of death in the world today. But regardless of isolated stories about HIV cure in one patient and a modest success in a clinical vaccine trial, a perfect ...
Comments
Please enable JavaScript to view thecomments powered by Disqus.Information & Contributors
Information
Published In
March 2021
200 pages
ISBN:9781450387897
DOI:10.1145/3460238
Copyright © 2021 ACM.
Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected]
Publisher
Association for Computing Machinery
New York, NY, United States
Publication History
Published: 20 July 2021
Check for updates
Author Tags
Qualifiers
- Research-article
- Research
- Refereed limited
Conference
ICBET '21
ICBET '21: 2021 11th International Conference on Biomedical Engineering and Technology
March 17 - 20, 2021
Tokyo, Japan
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 93Total Downloads
- Downloads (Last 12 months)21
- Downloads (Last 6 weeks)7
Reflects downloads up to 30 Nov 2024
Other Metrics
Citations
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Sign inFull Access
View options
View or Download as a PDF file.
PDFeReader
View online with eReader.
eReaderHTML Format
View this article in HTML Format.
HTML Format